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Abstract
K
+ channel interacting protein 1 (KChIP1) is a neuronal calcium sensor (NCS) protein that interacts with multiple
intracellular molecules. Its physiological function, however, remains largely unknown. We report that KChIP1 is pre-
dominantly expressed at GABAergic synapses of a subset of parvalbumin-positive neurons in the brain. Forced
expression of KChIP1 in cultured hippocampal neurons increased the frequency of miniature inhibitory postsynap-
tic currents (mIPSCs), reduced paired pulse facilitation of autaptic IPSCs, and decreases potassium current density.
Furthermore, genetic ablation of KChIP1 potentiated potassium current density in neurons and caused a robust
enhancement of anxiety-like behavior in mice. Our study suggests that KChIP1 is a synaptic protein that regulates
behavioral anxiety by modulating inhibitory synaptic transmission, and drugs that act on KChIP1 may help to treat
patients with mood disorders including anxiety.
Background
Neuronal calcium sensor (NCS) proteins contain EF-
hand calcium binding domains and are conserved
throughout evolution [1-3]. In humans, they are
encoded by 14 genes, some of which alternatively
splice during transcription. Based on the order of their
evolutionary appearance, NCS proteins are classified
into class A to E5 subfamilies [1,4]. Four KChIP pro-
teins constitute the fifth subfamily (Class E) and are
unique to mammals. KChIPs interact with voltage-
gated potassium channels and presenilins [5-8].
KChIP1, KChIP3, KChIP4 are expressed predominantly
in brain, while KChIP2 is highly expressed in both
heart and brain [7,9].
Frequenin, the Drosophila NCS-1, increases neuro-
transmitter release at the neuromuscular junction and
has been implicated in synaptic efficacy [10]. Gene dis-
ruption of NCS-1 in C. elegans causes defects in associa-
tive learning and memory, suggesting an involvement in
regulating synaptic plasticity [11]. Moreover, mammalian
NCS-1 was recently reported to facilitate P/Q-type
calcium currents at presynaptic terminals of the calyx of
Held synapse [12]. Similarly, KChIPs have been sug-
gested to function as the ß (modulatory) subunit of fast
transient (A-type) potassium channels. Potassium chan-
nels are responsible in part for repolarizing the plasma
membrane during action potentials [13]. Kv4 potassium
channels are voltage-gated fast transient (A-type) chan-
nels that modulate firing rates and shape first spike
latency. Kv1 and Kv3 subunits are found at presynaptic
nerve terminals [13], whereas Kv4.2 is primarily in post-
synaptic membranes [14,15]. Inactivation of KChIP3 in
mouse neurons results in enhanced long-term potentia-
tion (LTP) via down-regulation of Kv4-channel activity
[16], further supporting its role in modulating potassium
channels in vivo [8]. KChIPs, NCS-1, and frequenin
interact with potassium channels (e.g., Kv4.2 and Kv4.3)
modulating their trafficking and kinetic properties, sug-
gesting that NCS proteins affect the physiological
actions of potassium channels in neurons [7,8,17-27].
The present study investigated KChIP1 expression in the
mouse brain and its function. KChIP1 is predominantly
localized in a subpopulation of parvalbumin-positive
GABAergic neurons. Patch-clamp recordings revealed that
KChIP1 facilitated GABA-mediated IPSCs by increasing
presynaptic transmitter release. KChIP1 over-expression
decreased potassium current density whereas ablation of
KChIP1 expression resulted in increased potassium
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KChIP1 knockout (KO) mice exhibited enhanced anxiety-
like behavior compared to wildtype (WT) mice. Our
results provide the first evidence that KChIP1 plays an
important role in modulating inhibitory synaptic transmis-
sion and contributes to behavioral anxiety.
Methods
Neuronal cell culture and reagents
Primary hippocampal and cortical neurons were disso-
ciated from newborn or E18 rats, respectively, and
maintained in culture for 1-3 weeks as described pre-
viously [28]. Primary cerebellum cultures with enriched
P u r k i n j en e u r o n sw e r em a d ea sp r e v i o u s l yd e s c r i b e d
[29]. Anti-KChIP1 monoclonal antibody was commer-
cially generated [9]. Anti-SV2 was a gift from Dr. K.M.
Buckley. Anti-synaptophysin, anti-calbindin and anti-
enhanced green fluorescence protein (EGFP) were pur-
chased from Sigma (St. Louis, MO) and Clontech (Palo
Alto, CA), respectively.
Plasmids
The cDNA encoding KChIP1 was cloned into pEGFPN
(Clontech) and pcDNA3.1(-)MycHis (Invitrogen, San
Diego, CA) by PCR to generate plasmids expressing
C-terminally tagged KChIP1-EGFP and KChIP1-mycHis
in mammalian cells. Primers for PCR were: 5’-gggaattcgc-
caccatgggggccgtcatgggcacc-3’ (forward) and 5’-ggggatcca-
catgacattttgaaacagctggag-3’ (reverse). The coding sequence
of KChIP1 was cloned into pGEX4T2 (Amersham,
Uppsala, Sweden) to express a GST-KChIP1 fusion pro-
tein. All plasmids were confirmed by sequencing. For
expressing KChIP1 in neurons, EGFP and KChIP1-EGFP
cDNAs were excised from pEGFPN2 and pEGFPN2-
KChIP1 plasmids by Eco RI and Not I digestion, respec-
tively. The fragments were then cloned into a Sma I
digested pSFV1 plasmid (Invitrogen).
Fusion protein and antibody preparation
GST-KChIP1 fusion protein was produced and purified
following the manufacturer’sp r o t o c o l .T h eG S T -
KChIP1 protein was used to immunize rabbits in order
to raise polyclonal anti-KChIP1 antibodies. Antibody
production was performed by Immungenex (San
Diego, CA).
In situ hybridization
Non-radioactive in situ hybridization was performed
essentially as described previously [14]. Briefly, adult mice
(2-4 months) were perfused and fixed with 4% paraformal-
dehyde. Brains were dissected and fixed overnight. Fifty-
micron thick cryo-cut sections were obtained. Antisense
and sense RNA probes were in vitro transcribed and
labeled using KChIP1 cDNA fragments as templates and a
mixture of nucleotides containing digoxygenin-UTP.
Hybridization was carried out at 65°C overnight. Signals
were detected with an alkaline phosphatase-conjugated
goat anti-digoxygenin antibody and developed using NBT/
BCIP. Immunostaining was performed after in situ hybri-
dization. Sections were analyzed under either deconvolu-
tion or confocal microscopy.
Viral infection
We constructed a fusion protein between EGFP and
KChIP1, and inserted the fused gene or EGFP alone
under the CMV promoter into a Semliki Forest Virus
vector (pSFV, Invitrogen). pSFV1/EGFP, pSFV1/
KChIP1-EGFP, and virus Helper 2 DNA were linearized
by Spe I. One μgD N Aw a st r a n s c r i b e din vitro using
t h em M e s s a g em M a c h i n ek i t( A m b i o n ,A u s t i n ,T X ) .
pSFV1 viral particles were generated according to
instructions provided by Invitrogen. For infection of pri-
mary neurons, the original culture medium was changed
to a serum-free medium. Viral particles pre-treated with
chymotrypsin (Sigma) were added to the cultures at a 1
to 10 dilution. The infection was performed for 1 hour
at 37°C, followed by replacement of the infection med-
ium with conditioned culture medium. Infected neurons
were monitored for expression of EGFP and used for
patch-clamp recordings 18-30 h later.
Immunoassays
Immunoprecipitation, immunoblotting, and immuno-
fluorescence were performed essentially as described pre-
viously [30,31]. Briefly, cells were rinsed once with PBS
and lysed on ice in 0.7% NP-40 buffer (10 mM HEPES,
pH7.5, 142.4 mM KCl, 5 mM MgCl2,1m ME G T A ,a n d
0.7% NP-40). Insoluble cell debris was cleared by centri-
fugation at 14,000 rpm at 4°C for 30 min in an Eppendorf
centrifuge, and the supernatants were collected for
immunoprecipitation. Antibodies for immunoprecipita-
tion (3 μg) and protein G beads (25 μl) were added to the
lysates and mixed at 4°C overnight with a nutator.
Following precipitation, protein-antibody-bead com-
plexes were washed at least three times in 0.7% NP-40
buffer. The proteins were then separated on a 4-20%
Tris-Glycine gel (Invitrogen), electro-transferred to
PVDF membranes (Millipore, Billerica, MA), immuno-
dectected with appropriate antibodies, and developed
using an ECL kit (Amersham). Because the molecular
weight of KChIP is similar to that of the IgG light chain,
immunoprecipitation of KChIP1 was performed using
beads to which the antibody was immobilized by a Seiz ×
Mammalian Immunoprecipitation kit (Pierce, Rockford,
IL). For immunofluorescence staining, cells were grown
on circular cover slips in 24-well culture dishes, fixed
with 3.7% paraformaldehyde for 15 min, permeabilized
with 0.1% Tween-20 for 10 min, and stained with
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tion with a Cy2- or Cy3-labeled secondary antibody for
1 h. Cells were washed, cover slipped in anti-fade med-
ium (Fisher, Pittsburgh, PA), and analyzed under confo-
cal microscopy.
Brain sections were analyzed by immunohistochemis-
try as follows. Adult Sprague Dawley rats were anesthe-
tized with nembutal and perfused with PBS followed by
4% formaldehyde in PBS (pH 7.4) using intracardiac
catheterization. The brain was removed and fixed for an
additional hour, after which it was rinsed in PBS, and
80 μm thick vibratome sections were cut. Brain sections
were permeabilized in 0.1% Triton X-100, 1% normal
donkey serum, and 1% cold water fish gelatin (Sigma) in
PBS for 30 min. Sections were then incubated in pri-
mary antibody for 18 h at 4°C and washed in buffer, fol-
lowed by further incubation with the appropriate
secondary antibody (Jackson ImmunoResearch, West
Grove, PA) in PBS for 1 hr at 4°C. Sections were rinsed
in PBS, mounted in Gelvatol, and examined under con-
focal microscopy.
Expression and recording of Kv4.3 channels in Xenopus
oocytes
cDNAs encoding Kv4.3, KChIP1, or KChIP1-EGFP were
subcloned into the pCS2 plasmid. Capped RNAs were
made using Message Machine RNA polymerase kits
(Ambion) and verified by gel electrophoresis. Xenopus
oocytes were co-injected with Kv4.3 (5 ng) and either
EGFP (10 ng), KChIP1 (10 ng), or KChIP1-EGFP RNAs
(20 ng), and maintained in ND96 solution (96 mM
NaCl, 2 mM KCl, 1.8 mM CaCl2,1m MM g C l 2,a n d
5 mM HEPES, pH 7.4). Kv4.3 potassium currents were
recorded under two-electrode voltage clamp at a holding
potential of -100 mV (Amplifier Model OC-725A, War-
ner Instrument, Hamden, CT). Recording electrodes
were filled with 2 M KCl and had resistances between
0.3 and 1.0 mΩ. Currents were sampled at 5-10 kHz
and filtered at 1-2 kHz. All recordings were performed
at room temperature, and oocytes were perfused con-
tinuously with an external solution containing 96 mM
NaCl, 2 mM KCl, 2 mM CaCl2,1m MM g C l 2,1 0m M
HEPES (pH 7.4). Data collection and analysis were per-
formed using the pClamp 9.0 software program (Axon
Instruments, Foster City, CA).
Whole-cell patch-clamp recording
Autaptic recordings were made from somas of isolated,
single hippocampal neurons in low-density culture con-
ditions with patch pipettes (4-6 MΩ resistance) that
were filled with an internal solution consisting of
(in mM): 140 potassium gluconate, 17.5 KCl, 9 NaCl,
1M g C l 2, 10 HEPES, and 0.2 EGTA, at pH 7.4 [28,32].
The standard external solution contained 150 mM
NaCl, 3 mM KCl, 10 mM HEPES, 5 mM glucose, 2 mM
CaCl2,5 0μM D-2-amino-5-phosphonovalerate (APV),
and 10 μM CNQX at pH 7.4. For the paired pulse facili-
tation experiments, 2 mM CaCl2 was replaced by 1 mM
CaCl2 and 3 mM MgCl2. The currents were low-pass fil-
tered at 2-5 kHz and digitally sampled at 10-20 kHz.
Capacitative currents were subtracted and blanked. Illu-
strated traces represent an average of 4-8 responses. For
experiments studying mIPSCs, TTX (1 μM) was added
to block Na
+ channels and resulting action currents. For
recording K
+ currents, we used an external solution
comprised of 115 mM NaCl, 2.5 mM KCl, 1.5 mM
MgCl2,1 0m MH E P E S ,a n d0 . 1m MB A P T A ;1μM
TTX and 3 mM CoCl2 were added to inhibit Na
+ and
Ca
2+ currents, respectively. Potassium currents were
evoked with a series of incremental voltage steps
of 100 ms duration to 45 mV from a holding potential
of -75 mV. Steady-state current amplitudes were mea-
sured 75 ms after the initiation of each voltage step
and normalized to cell capacitance. For recordings
of Ca
2+-channelmediated Ba
2+ currents, the external
solution contained 160 mM TEA-Cl, 2 mM BaCl2,a n d
1 0m MH E P E S - C s O H .I na d d i t i o n ,1μM TTX was
added to block Na
+ currents. A cesium gluconate-based
solution was used as the internal solution [28]. Voltage-
activated Ba
2+ currents were evoked by applying a 105
msec step to a test potential of 0 mV every 10 sec from
a holding potential of -80 mV. The peak Ba
2+ currents
were calculated by subtraction of Cd
2+-s e n s i t i v eB a
2+
current and normalized to cell capacitance. Solution
changes were made with fast-flow, gravity-fed flow tubes
gated by valves. Data acquisition and analysis were
made with pClamp 8 (Axon Instruments, Union City,
CA) or a mini analysis program (Synaptosoft, Decatur,
GA). Results are expressed as mean ± SE. All experi-
ments were performed at room temperature.
Behavioral measurements
Hot-plate and tail-flick test: KChIP1
-/- mice were gener-
ated, genotyped and breed as described[33]. In the
hot-plate test, mice were placed on a standard thermal
hotplate with a heated surface (55°C) (Columbus Instru-
ments, Columbus, OH). The latency for nociceptive
responses was recorded with a cutoff time of 30 sec-
onds. The spinal nociceptive tail-flick reflex was evoked
by radiant heat (Columbus Instruments, Columbus, OH)
applied to the underside of the tail, and latencies were
measured with a cutoff time of 10 seconds.
Rota-rod: Motor functions were tested using the Rota-
Rod test (Med Associates, St Albans, VT,) as previously
described [3]. Briefly, animals were trained on a rotating
drum and tested the following day with increasing velo-
city. Measures were taken of the duration each animal
was able to maintain its balance walking on the rotating
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motor function.
Open-field activity: The Activity Monitor system from
Medical Associates (Med Associates, St Albans, VT,)
was used to record locomotor activity as published pre-
viously [3]. Briefly, each subject was placed in the center
of the open-field and activity was measured for
30 minutes and was recorded via a camera and stored
for offline analysis.
Elevated plus maze test: The elevated plus maze (Med
Associates, St Albans, VT,) consists of two open arms
and two closed arms situated opposite each other and
separated by a 6 cm square center platform. Each run-
way is 6 cm wide and 35 cm long. For each test, the ani-
mal was placed in the center square and allowed to
move freely for five minutes. Open arm entries were
defined as the mouse having all four paws onto the
open arm. The number of entries and time spent in
each arm was recorded.
Light/Dark emergence task: The Light/Dark test was
performed as previously [3].B r i e f l y ,t h ea p p a r a t u si sa
modified chamber (40 × 15.9 × 21.3 cm) separated into
two compartments with a small opening (3.5 × 6 cm)
between compartments. One compartment is completely
dark, and the other is very bright. Mice were individu-
ally placed into the dark chamber of the box with the
exit blocked for 5 seconds, after which the door lifted
open and the mice were allowed to freely explore either
compartment for 10 minutes. Time spent in the light
chamber and light/dark compartment transitions were
recorded.
Figure 1 KChIP1 expression in the adult mouse brain. a, b: In situ hybridization. Adult mouse brain sections were hybridized in situ with an anti-
sense RNA probe synthesized using KChIP1 cDNA as the template. Coronal (a) and sagittal (b) views are shown. Hybridization signals are seen in a
subset of neurons distributed in the cerebral cortex, hippocampus, and thalamus. High expression of KChIP1 was detected in the medial habenular
nucleus (a, MHb), the reticular thalamic nucleus (a and b, Rt), the dorsomedial part of the ventromedial hypothalamic nucleus (a, VMHDM), and the
Purkinje cell layer of the cerebellum (b, Ce). The montage was produced from photographs taken with a deconvolution microscope using a 5×
objective and Slidebook software (Intelligent Imaging Innovations, Inc.). c: Immunohistochemical detection of KChIP1 in the brain. Adult mouse
brain sections were immunostained with a polyclonal anti-KChIP1 antibody. Expression of KChIP1 was analyzed under confocal microscopy. The
distribution of KChIP1 protein was similar to that of KChIP1 mRNA detected by in situ hybridization. KChIP1 was detected in a subpopulation of
neurons in the cerebral cortex (Cx, yellow arrow); high levels of KChIP1 were observed in the medial habenular nucleus (MHb, yellow arrow), reticular
thalamic nucleus (Rt, yellow arrow), and Purkinje cell layer of the cerebellum (Ce, yellow arrow). Bar = 50 μm in Cx and 100 μm in MHb, Rt, and Ce.
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KChIP1 expression in the adult mouse brain
The expression of KChIP1 in the adult mouse brain was
initially investigated by in situ hybridization. Two probes
were synthesized using KChIP1 cDNA as templates.
One included the 3’ UTR and partial coding sequences,
while the other consisted of the 5’UTR and partial cod-
ing sequences. Similar results were obtained using both
probes. Consistent with previous reports, KChIP1
expression was detected in multiple regions of the adult
brain, including cortex, hippocampus, thalamus,
hypothalamus, and cerebellum (Fig 1a and 1b) [2,9].
Individual KChIP1-positive neurons were found in all
layers of the cerebral cortex. KChIP1-expressing neurons
were scattered in the hippocampal CA1-3 region as well
as in the dentate gyrus. In the cerebellum, KChIP1 was
detected in the Purkinje cell layer only. A faint KChIP1
hybridization signal was observed in the molecular and
granular layers of the cerebellum. In the hypothalamus,
KChIP1-positive cells were concentrated in dorsomedial
regions of the ventromedial hypothalamic nucleus. Only
a few labeled cells were scattered in the ventrolateral
and posterior hypothalamic areas. Interestingly, KChIP1
is expressed very highly in the medial habenular nucleus
and the reticular thalamic nucleus. Hybridization signals
were also seen in a small population of neurons in the
oriens, pyramidale, and radiatum of the striatum. No
significant hybridization signal was detected in the
KChIP1 deficient mouse brain. Hybridization with sense
probes generated only a faint background signal, con-
firming the specificity of the antisense probes (not
shown).
To examine the localization of KChIP1 protein in the
brain, we raised a polyclonal antibody against KChIP1
in rabbit. In agreement with the in situ hybridization
results, immunohistochemical detection revealed
KChIP1 expression in a subpopulation of neurons in
the cerebral cortex, hippocampus (not shown), and in
Figure 2 Synaptic localization of KChIP1 in a subset of parvalbulmin-positive GABAergic neurons presynaptically in vivo. a: Adult rat
cortex was immunostained with a polyclonal antibody against KChIP1 (green), and b: a monoclonal antibody against synaptophysin (red), and c:
a monoclonal antibody against GFAP (blue). Sections were examined under confocal microscopy. d: An overlay image shows colocalization
(yellow) of KChIP1 and synaptophysin at the plasma membrane of neuronal cell bodies and processes. No GFAP-labeled cells were KChIP1
positive. Arrows indicate colocalization of KChIP1 and synaptophysin. Bar = 40 μm.
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KChIP1-EGFP was detected by immunoblot analysis in neurons infected with KChIP1-EGFP (KChIP1) but not in neurons infected with EGFP alone.
Detection of actin in the lysates with an anti-actin antibody is shown as a loading control. b: Representative recordings from EGFP+ (Control)
and KChIP1-EGFP neurons (KChIP1) are shown. c: The paired pulse ratio (PPR) recorded in control cells was significantly larger than that seen in
KChIP1-expressing cells (*P < 0.01). d, E: mIPSCs from autaptic inhibitory neurons. Representative mIPSC recordings are shown from EGFP+ (d)
and KChIP1-EGFP+ neurons (e). f: Cumulative probability of amplitude and averaged mIPSCs (inset) from the same two cells as on f and e. g: The
frequency of mIPSCs in cells expressing KChIP1 (0.88 ± 0.14 Hz) was more than twice that observed in control cells expressing EGFP alone (0.37
± 0.13; *P < 0.05). h: There was no difference in the amplitude distribution of mIPSCs in these neurons (KChIP-EGFP: filled dots; EGFP alone:
empty dots).
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mic nucleus, and medial habenular nucleus (Fig. 1c).
Similar results were observed in rat and mouse. Thus,
KChIP1 is expressed in a subpopulation of neurons
located in multiple regions of the adult mammalian
brain.
Synaptic localization of KChIP1 in a subset of
parvalbumin-positive GABAergic neurons
We have previously shown KChIP1 is predominantly
expressed by a subpopulation of parvalbumin-positive
GABAergic neurons[33]. However, an exception to this
rule occurred in the medial habenular nucleus, where
neurons were decorated by the anti-KChIP1 antibody
but not the anti-parvalbumin antibody (Fig. 1b and 1c).
Figure 4 KChIP1 decreases potassium but not calcium current densities. a: Inhibition of potassium currents by KChIP1. Representative
recordings from control neurons expressing EGFP alone or KChIP1-EGFP. Potassium current density in KChIP1+ neurons was significantly smaller
than that seen in control (*P < 0.01, n = 18). Whole-cell potassium currents were evoked by a voltage step to -15 mV from a holding potential
of -75 mV. Steady-state amplitudes were normalized to cell capacitance. b Expression of KChIP1 does not affect Ca
2+ channels. Representative
recordings from control (EGFP+) and KChIP1+ (KChIP1-EGFP) neurons. Ba
2+ current density in KChIP+ neurons (143.17 ± 11.1 pA/pF, n = 11) was
similar to that observed in controls (124.3 ± 8.9 pA/pF, n =12; *P > 0.1). Whole cell Ba
2+ currents were evoked by a voltage step to 0 mV from a
holding potential of -80 mV.
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nergic neurons [34]. We further examined the subcellu-
lar localization of KChIP1 using both monoclonal (not
shown) and polyclonal antibodies. In primary rat cere-
brocortical cultures, KChIP1 was visualized in a subset of
neurons (<10%) at synaptic bouton-like structures that
clustered at the plasma membrane of both cell bodies
and processes. Staining was abolished by pre-absorption
of the antibodies with a KChIP1-GST fusion protein but
not with GST protein alone. KChIP1-positive structures
were co-labeled with antibodies against synaptophysin
and synaptic vesicle protein 2 (SV2) (not shown), consis-
tent with a presynaptic localization of KChIP1. Moreover,
immunohistochemical analysis of adult rat brain revealed
colocalization of KChIP1 and synaptophysin in a punc-
tate pattern on the plasma membrane (Fig 2). GFAP-
positive cells did not label for KChIP1 (Fig 2c). These
results indicate a predominantly neuronal expression of
KChIP1 in the adult brain and further verify the presy-
naptic localization of KChIP1 in vivo.
Overexpression of KChIP1 facilitates GABA-mediated
synaptic transmission in cultured hippocampal neurons
We investigated the role of KChIP1 in modulating inhibi-
tory synaptic transmission in cultured hippocampal neu-
rons infected with recombinant Semliki Forest viral (SFV)
particles encoding either a KChIP1-EGFP fusion protein
or EGFP protein alone. Expression of KChIP1-EGFP was
confirmed by immunoblotting with an anti-KChIP1 anti-
body (Fig. 3a). To assess its effect on physiological activity,
we overexpressed KChIP1 in this neuronal cell type
because only a subset of hippocampal neurons expressed
endogenous KChIP1 and at relatively low levels. Using
patch electrodes, we recorded autaptic GABA-mediated
IPSCs from isolated EGFP-labeled neurons. IPSCs in these
cultures were mediated exclusively by GABAA receptors
that were blocked by the antagonists bicuculline or picro-
toxinin [35]. Expression of KChIP1-EGFP had no signifi-
cant effect on the decay time constants of autaptic GABA
IPSCs (48.0 ± 6.7 ms, n = 7 for EGFP; 35.7 ± 3.0 ms, n =8
for KChIP1-EGFP; P >0 . 1b yS t u d e n t ’s t-test). The peak
amplitude of the IPSCs was 373 ± 108 pA (n =8 )i n
KChIP1-EGFP-positive neurons, while it was 233 ± 67.2
pA (n = 7) in EGFP-labeled neurons. Unlike the amplitude
of GABA-mediated IPSCs, paired pulse facilitation is inde-
pendent of postsynaptic receptor density or the number of
synapses [36]. Here, we examined the effect of KChIP1
expression on this purely presynaptic phenomenon. Paired
stimuli at intervals of 40 ms resulted in a 119 ± 12.8%
increase in the amplitude of the second autaptic GABA
IPSC in neurons expressing EGFP alone (n =7 ) .I nc o n -
trast, for KChIP1-EGFP neurons, the paired pulse ratio
was substantially reduced (74 ± 5.7%, n =8 ;P < 0.01).
This finding was consistent with the notion that KChIP1-
EGFP expression increased the presynaptic release prob-
ability of GABA (Fig.3b and 3c). In agreement with the
paired pulse facilitation results, the frequency of sponta-
neous autaptic miniature IPSCs (mIPSCs) in neurons
expressing KChIP1-EGFP (0.88 ± 0.14 Hz, n = 12) was sig-
nificantly higher than that seen in neurons expressing
EGFP alone (0.37 ± 0.13 Hz, n =1 0 ;P < 0.05) (Fig. 3d,e
and 3g). However, there was no difference in the mean
amplitude or amplitude distribution of mIPSCs in neurons
expressing KChIP1-EGFP and control EGFP-positive neu-
rons (Fig 3f and 3h). These results suggest that KChIP1
potentiates GABA-mediated inhibitory synaptic transmis-
sion via an increase in presynaptic GABA release.
KChIP1 inhibits potassium currents in cultured
hippocampal neurons
To study the possible mechanism of KChIP1-induced
presynaptic potentiation, we monitored whole-cell
potassium and calcium currents in cultured hippocam-
pal neurons infected with either KChIP1-EGFP or EGFP
constructs (Fig. 4a, b). To minimize the effect of cell
size, currents were normalized to neuronal membrane
capacitance. Potassium current density in neurons
expressing KChIP1-EGFP was significantly smaller (65 ±
7.6 pA/pF, n =9 )t h a ni nE G F P - e x p r e s s i n gn e u r o n s
(93.3 ± 2.9 pA/pF, n =9 ;P < 0.01). In contrast, KChIP1
exhibited no significant effect on calcium current den-
sity. These results suggest that KChIP1 modulates neu-
ronal potassium channels but not calcium channels
under these conditions. Of note, the K
+ current
recorded in this study is largely non-inactivating in nat-
ure, indicating that a non-A-type K
+ channel is predo-
minantly involved.
KChIP1 was previously demonstrated to potentiate
Kv4 (A-type, fast inactivating) potassium channels in
Xenopus oocytes [7]. In contrast, our results indicate
the opposite effect of KChIP1 on non-inactivating potas-
sium channels in cultured rat neurons. In order to
ensure that our findings were not due to the EGFP moi-
ety that was used to tag KChIP1 in our expression vec-
tor rather than KChIP1 itself, we compared the
properties of KChIP1 and KChIP1-EGFP proteins.
KChIP1-EGFP fusion protein co-immunoprecipitated
with Kv4.3 in HEK293 cells co-transfected with cDNAs
encoding KChIP1-EGFP and Kv4.3 (Fig 5a). We found
in Xenopus oocytes that Kv4.3 current density was
potentiated by expression of either KChIP1-EGFP fusion
protein (to 5.1 ± 1.7 μA/pF, n = 10) or KChIP1 alone
(to 4.1 ± 2.0 μA/pF, n = 9). Potentiation could be attrib-
uted to a slowing of channel inactivation, as previously
demonstrated for KChIP1 (Fig 5c and 5d). No significant
difference in the potency of modulation of Kv4.3 chan-
nels was found between KChIP1-EGFP fusion protein
and KChIP1. These results show that KChIP1-EGFP
Xia et al. Molecular Brain 2010, 3:23
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results are further supported by the recent findings that
GFP-tagged KChIP1 functionally stimulates Kv4.2 traf-
ficking in transfected cells [27,37]. Hence, our results
demonstrating a difference between the effects of
KChIP1 on potassium channelm o d u l a t i o ni nX e n o p u s
oocytes and in neurons cannot be attributed to differing
effects of KChIP1-EGFP and KChIP1.
Disruption of mouse KChIP1 gene potentiates potassium
currents in cultured Purkinje neurons
To further investigate KChIP1 function in vivo, we gen-
erated mice with a genetic disruption of the KChIP1
gene. Expression of KChIP1a and KChIP1b, two
reported KChIP1 splice variants [7,38], are ablated in
the brains of these knockout (KO) mice (Fig. 4a). Since
Purkinje neurons represent neurons that express high
Figure 5 KChIP1 inhibits potassium currents in cultured hippocampal neurons. a: Co-immunoprecipitation of Kv4.3 and KChIP1-EGFP.
HEK293 cell lysates co-expressing Flag-tagged Kv4.3 and KChIP1-EGFP were immunoprecipitated with an anti-Flag antibody (left panel; IP: Kv4.3)
or an anti-EGFP antibody (right panel; IP: EGFP) followed by immunoblotting with anti-EGFP (left panel; IB: EGFP) or anti-Flag (right panel; IB:
Kv4.3), respectively. b: Potentiation of Kv4.3 current density by Kv4.3-EGFP in Xenopus oocytes. Kv4.3 was co-expressed with either KChIP1-EGFP
fusion protein, KChIP1, or EGFP in Xenopus oocytes. KChIP1-EGFP and KChIP1 but not EGFP significantly increased Kv4.3 current density (*P <
0.001). c, d: KChIP1-EGFP modulates inactivation of Kv4.3 in Xenopus oocytes. Kv4.3 was co-expressed with either KChIP1-EGFP fusion protein
(black line), KChIP1 (red line), or EGFP (green line) in Xenopus oocytes. Expression of KChIP1-EGFP or KChIP1 enhanced inactivation of Kv4.3 from
both the open state (c) and the closed state (d) compared with EGFP alone.
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Page 9 of 15Figure 6 Disruption of mouse KChIP1 gene potentiates potassium currents in cultured Purkinje neurons. a: Lack of KChIP1 mRNA in
KChIP1
-/- mouse brain tissue. KChIP1a and KChIP1b mRNAs in wild-type (WT) and KChIP1
-/- (KO) mouse brain were analyzed by RT-PCR. The
brain tissues examined include cerebellum (Ce), hippocampus (Hipp), cortex (Cx) and thalamus (Tha). Expression of GAPDH was monitored as a
positive control. b: Primary cultures of Purkinje cells from KChIP1
-/- mouse cerebella. A phase contrast image (left panel) and an
immunofluorescence image of Purkinje cells stained by with anti-calbindin antibody (right panel) are illustrated. c, d: Potentiation of potassium
currents in KChIP1
-/- Purkinje cells. Representative recordings from wild-type (WT) and KChIP1
-/- (KO) Purkinje cells (c). Potassium current density
in WT was significantly smaller than that seen in KO neurons (d,* P < 0.05). Whole-cell potassium currents were evoked by a voltage step to -15
mV from a holding potential of -75 mV. Steady-state amplitudes were normalized to cell capacitance.
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Page 10 of 15levels of KChIP1 and are morphologically identifiable in
culture, we compared potassium currents in cultured
Purkinje neurons generated from KChIP1 wild-type
(WT) mice and KChIP1 KO mice. Cultured mouse Pur-
kinje cells were morphologically identified under micro-
scopy and immuno-verified with anti-calbindin antibody
staining after electrophysiological recording (Fig. 6b).
Potassium currents were normalized to neuronal mem-
brane capacitance. We found that potassium current
density in KChIP1 KO Purkinje cells was significantly
larger (11.3 ± 0.95 pA/pF, n = 13) than in WT Purkinje
neurons (8.8 ± 0.60 pA/pF, n = 13; P <0 . 0 5 )( F i g .6 c
a n d6 d ) .T h u s ,a b l a t i o no fK C h I P 1 aa n dK C h I P 1 b
resulted in increased potassium current density in
Figure 7 KChIP1 KO mice display enhanced anxiety-like behavior. a: In the light/dark test, KChIP1 KO mice (n = 6) spent significantly less
time in the light compartment compared to WT controls (n = 5) (*P < 0.05.). b: In the open field test, KChIP1 KO mice had significantly less
ambulatory counts compared to WT controls (n = 7). (* P < 0.02). c: KChIP1 KO mice (n = 9) travelled significantly less within the centre area
compared to WT controls (n = 7). d: In the elevated plus maze test, KChIP1 KO mice (n = 9) spent significantly less time in the open arms to WT
mice (n = 7), however e: KChIP1 KO mice (n = 9) made similar amount of entries into the arms compared to WT controls (n = 7) (* P < 0.05). f:
In a rota-rod test for motor performance, KChIP1 KO mice (n = 6) exhibited similar falling latencies as WT control mice (n = 6). g: On a thermal
hot plate test, KChIP1 KO mice (n = 6) displayed similar latencies for nociceptive behavior display as WT control mice (n = 6). h: In a tail flick
assay, KChIP1 KO mice (n = 6) displayed similar latencies for tail flicks as WT control mice (n = 6).
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those in neurons overexpressing KChIP1-EGFP and pro-
vide further evidence that KChIP1 inhibits neuronal
potassium channels in vivo.
KChIP1 KO mice display enhanced anxiety-like behavior
Given our observations that KChIP1 potentiates presy-
naptic GABA release and that benzodiazepines, com-
monly used for the relief of anxiety, are thought to act
by enhancing the action of the inhibitory transmitter
G A B A ,w ei n v e s t i g a t e dt h ep o s s i b l er o l eo fK C h I P 1i n
anxiety-like behavior and compared KChIP1 KO and
WT mice in a battery of anxiety related tasks. In the
light/dark emergence task, where a box is separated into
light and dark compartments, KChIP1 KO mice spent a
significantly smaller percentage of the time in the light
compartment (17.72 ± 3.98 sec, n = 6) compared to WT
mice (28.51 ± 3.16 sec, n =5 ;P < 0.05) (Fig 7a) and
also made significantly fewer crossings between com-
partments (14.33 ± 2.75, n =6 )c o m p a r e dw i t hW T
mice (38.8 ± 5.08 sec, n =5 ;P < 0.005) (not shown). In
the open field paradigm, KChIP1 KO mice displayed sig-
nificantly less activity after2 5m i n u t e s( 5 7±1 0 . 9 2s e c ,
n = 9) and 30 minutes (83.33 ± 15.02 sec, n =9 )c o m -
pared to WT mice (192.67 ± 27.92 sec, n =9 ;
P < 0.005) and (202.43 ± 38.92 sec, n =9P < 0.02)
respectively (Fig. 7b). Furthermore, KChIP1 KO mice
travelled significantly less in the centre area (512.14 ±
160.64 sec, n = 9) compared to control mice (1351.75 ±
221.55 sec; n =7 ;P < 0.05) (Fig. 7c). In the elevated
plus maze task, KChIP1 KO mice spent a significantly
smaller percentage of the time in the open arms (7.81 ±
1.56 sec, n = 9) compared to WT mice (13.57 ± 2.04
n =7 ;P < 0.05) (Fig. 7d). Importantly, total number of
entries did not differ between KChIP1 KO and WT
mice (Fig 7e), confirming that the results are not due to
alterations in motor ability.
KChIP1 KO mice do not display sensory or motor deficits
KChIP1 KO mice (239.11 ± 72.69 sec, n =6 )a n dW T
mice (257.22 ± 22.06 sec, n = 6) displayed similar fall
latencies in the rota-rod test for motor performance (Fig
7f). Additionally, KChIP1 KO showed similar latencies
for nociceptive response in the hot plate test (9.18 ±
2.33 sec, n = 6) compared to WT mice (10.83 ± 1.42
sec, n = 6) (Fig 7g). Similarly, KChIP1 KO and control
mice showed similar latencies for tail flick responses
(6.26 sec ± 1.24 sec, n = 6) and (5.57 ± 0.24 sec, n =6 )
respectively (Fig. 7h).
Discussion
In this study, we employed two independent expe-
rimental approaches, in situ hybridization and immu-
nohistochemical staining, to detect KChIP1 in the
adult mammalian brain. We found that KChIP1 is
expressed in a subpopulation of neurons widely distrib-
uted in the cortex, thalamus, hypothalamus, hippocam-
pus, and amygdala. Additionally, high expression of
KChIP1 in the cerebellar Purkinje cell layer and the
thalamic reticular nucleus suggested an association
with inhibitory neurons. In support of this notion, neu-
rons expressing KChIP1 were also found to be parval-
bumin-positive. Our results are consistent with a
recent finding of KChIP1 expression in interneurons in
the rat brain [2]. Parvalbumin-containing neurons con-
stitute the largest subset of inhibitory GABAergic
interneurons in the brain [39]. These neurons are
often fast spiking and morphologically heterogeneous
[40,41]. The subset of parvalbumin-positive, GABAer-
gic cells expressing KChIP1 may represent a function-
ally distinct pool of inhibitory neurons. To test this
idea, we investigated the physiological effect of KChIP1
in central neurons. Most importantly, we found three
l i n e so fe v i d e n c et h a ts u g g e s tar o l ef o rK C h I P 1i n
enhancing inhibitory synaptic transmission via a presy-
naptic mechanism. First, KChIP1 localized to presy-
naptic structures in parvalbumin-expressing neurons.
Second, expression of KChIP1-EGFP in cultured hip-
pocampal neurons reduced the degree of paired pulse
facilitation observed in GABA-mediated IPSCs. Finally,
expression of KChIP1-EGFP increased the frequency
but not the amplitude of mIPSCs.
These findings can be compared to those on the
KChIP1 homologues NCS-1 and frequenin. Frequenin, a
Drosophila homologue of KChIP1, is enriched at
synapses. Transgenic flies overexpressing frequenin exhi-
bit frequency-dependent facilitation of neurotransmitter
release at the neuromuscular junction [10]. In C. elegans,
NCS-1 regulates associative learning and memory [11].
Recent studies suggest that mammalian NCS-1 contri-
butes to activity-dependent synaptic facilitation at presy-
naptic nerve terminals via an increase in calcium current
[12]. Thus, other neuronal calcium sensor proteins
appear to be involved in modulating synaptic efficacy and
plasticity[42]. However, despite our evidence for a presy-
naptic effect of KChIP1, our results do not totally exclude
the possibility of an additional postsynaptic function of
KChIP1, for example, by modulating Kv4 channels, which
may be predominately postsynaptic in localization. In
fact, KChIP1 and Kv4.3 are colocalized along the somato-
dendritic membranes of interneurons [2].
Here we explored the underlying mechanism of facili-
tation of inhibitory synaptic transmission by KChIP1.
Intriguingly, previous studies had suggested that KChIP1
increases potassium channel activity in non-neuronal
cells, including Xenopus oocytes and CHO cells
[8,18,23]. If this were the mechanism of action in neu-
rons, however, KChIP1 would inhibit rather than
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Page 12 of 15facilitate synaptic transmission, as we found. In contrast
to other NCS proteins, our studies suggest that KChIP1
facilitates inhibitory synaptic transmission in neurons by
inhibiting potassium channel activity rather than by
enhancing calcium channel currents. Along these lines,
we report here for the first time that overexpression of
KChIP1 inhibits whole-cell K
+ currents in cultured hip-
pocampal neurons. Consistent with this notion, genetic
ablation of KChIP1 potentiates potassium currents in
Purkinje cells. In addition, unlike NCS-1, overexpression
of KChIP1 had no direct effect on whole-cell calcium
currents. It remains unclear, however, why KChIP1
exhibits opposite effects on potassium currents in neu-
rons and in non-neuronal cells. The most likely explana-
tion is that different types of potassium channels are
involved; prior studies found that KChIP1 facilitated
Kv4 A-type (fast inactivating) K
+ currents, whereas we
observed that KChIP1 inhibited non-inactivating K
+
currents. Along these lines, it was recently reported
that KChIP1 and KChIP2 inhibit trafficking of
non-inactivating Kv1.5 K
+ channels, thus decreasing
their insertion into the plasma membrane [43]. This
finding offers a possible mechanism for our physiologi-
cal observations.
Recent studies suggest that parvalbumin-expressing
neurons constitute a subpopulation of GABAergic neu-
rons that are vulnerable in several neurodegenerative
and neuropsychiatric disorders. In the brains of Hun-
tington’s disease patients, for example, and mice expres-
sing mutant huntingtin protein, a large percentage of
parvalbumin-positive neurons selectively degenerate
[44,45]. Severe loss of parvalbumin-positive neurons is
also observed in human transmissible spongiform ence-
phalopathies (TSEs), prion diseases[46,47]. Furthermore,
a profound and selective loss of parvalbumin-positive
neurons is found in the hippocampus of patients with
schizophrenia, bipolar disorder and epilepsy[48-52]. In
fact, it has been suggested that impaired synaptic trans-
mission may contribute, at least in part, to the loss of
these neuronal populations [53,54]. Furthermore, benzo-
diazepines, commonly used for the relief of anxiety,
have long been understood to act by enhancing
GABAergic activity, although the mechanisms involved
in this effect are not yet fully understood. Here we
report that KChIP1 KO mice exhibited enhanced anxi-
ety-like behavior across a battery of anxiety related
tasks. They displayed avoidance of high, exposed, well
light open areas, and displayed less exploratory activity
than WT mice. These observations are consistent with
the anxiolytic effects of GABA receptor stimulation, and
s u g g e s tt h a tK C h I P 1 - d e p e n d e n tp o t e n t i a t i o no fp r e s y -
naptic GABA release is a mediator of anxiety. Impor-
tantly, KChIP1 KO mice did not exhibit deficiencies in
nociception or motor functions, indicating that KChIP1
protein may be selectively involved in the perception of
anxiety-related behavior. Given its expression in parval-
bumin-expressing neurons and its role in enhancing
inhibitory synaptic transmission, it will be important to
further investigate the potential role of KChIP1 in men-
tal health and neurodegenerative diseases.
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